There is a distinct subset of CXCL1+ fibroblasts in SLE lesions that not only recruit and activate neutrophils, increase the production of inflammatory mediators, reactive oxygen species, and NETs, but also promote neutrophil transformation to a low-density phenotype and delay apoptosis. The gene discussed is CXCL1; the disease is systemic lupus erythematosus.